Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1343 entries
Sorted by: Best Match Show Resources per page
Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment.

United European gastroenterology journal

Vijayvargiya P, Iturrino J, Camilleri M, Shin A, Vazquez-Roque M, Katzka DA, Snuggerud JR, Seime RJ.
PMID: 24724013
United European Gastroenterol J. 2014 Feb 01;2(1):38-46. doi: 10.1177/2050640613518774.

BACKGROUND: Patients with disorders of gastrointestinal function may undergo unnecessary treatment if misdiagnosed as motility disorders.OBJECTIVE: To report on clinical features, medical, surgical and psychiatric co-morbidities, and prior treatments of a patient cohort diagnosed concurrently with non-psychogenic rumination syndrome...

Cite
Vijayvargiya P, Iturrino J, Camilleri M, et al. Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment. United European Gastroenterol J. 2014;2(1):38-46doi: 10.1177/2050640613518774.
Vijayvargiya, P., Iturrino, J., Camilleri, M., Shin, A., Vazquez-Roque, M., Katzka, D. A., Snuggerud, J. R., & Seime, R. J. (2014). Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment. United European gastroenterology journal, 2(1), 38-46. https://doi.org/10.1177/2050640613518774
Vijayvargiya, Priya, et al. "Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment." United European gastroenterology journal vol. 2,1 (2014): 38-46. doi: https://doi.org/10.1177/2050640613518774
Vijayvargiya P, Iturrino J, Camilleri M, Shin A, Vazquez-Roque M, Katzka DA, Snuggerud JR, Seime RJ. Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment. United European Gastroenterol J. 2014 Feb 01;2(1):38-46. doi: 10.1177/2050640613518774. PMID: 24724013; PMCID: PMC3979495.
Copy Download .nbib Format: NLM
Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?.

United European gastroenterology journal

Biemans VB, Verstockt B.
PMID: 32640933
United European Gastroenterol J. 2020 Aug;8(7):753-754. doi: 10.1177/2050640620942641. Epub 2020 Jul 08.

No abstract available.

Cite
Biemans VB, Verstockt B. Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European Gastroenterol J. 2020;8(7):753-754doi: 10.1177/2050640620942641.
Biemans, V. B., & Verstockt, B. (2020). Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European gastroenterology journal, 8(7), 753-754. https://doi.org/10.1177/2050640620942641
Biemans, Vince Bc, and Verstockt, Bram. "Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?." United European gastroenterology journal vol. 8,7 (2020): 753-754. doi: https://doi.org/10.1177/2050640620942641
Biemans VB, Verstockt B. Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European Gastroenterol J. 2020 Aug;8(7):753-754. doi: 10.1177/2050640620942641. Epub 2020 Jul 08. PMID: 32640933; PMCID: PMC7434994.
Copy Download .nbib Format: NLM
The microbiome in pancreatic diseases: Recent advances and future perspectives.

United European gastroenterology journal

Ammer-Herrmenau C, Pfisterer N, Weingarten MF, Neesse A.
PMID: 32703080
United European Gastroenterol J. 2020 Oct;8(8):878-885. doi: 10.1177/2050640620944720. Epub 2020 Jul 23.

The human microbiota exerts multiple physiological functions such as the regulation of metabolic and inflammatory processes. High-throughput sequencing techniques such as next-generation sequencing have become widely available in preclinical and clinical settings and have exponentially increased our knowledge about...

Cite
Ammer-Herrmenau C, Pfisterer N, Weingarten MF, et al. The microbiome in pancreatic diseases: Recent advances and future perspectives. United European Gastroenterol J. 2020;8(8):878-885doi: 10.1177/2050640620944720.
Ammer-Herrmenau, C., Pfisterer, N., Weingarten, M. F., & Neesse, A. (2020). The microbiome in pancreatic diseases: Recent advances and future perspectives. United European gastroenterology journal, 8(8), 878-885. https://doi.org/10.1177/2050640620944720
Ammer-Herrmenau, Christoph, et al. "The microbiome in pancreatic diseases: Recent advances and future perspectives." United European gastroenterology journal vol. 8,8 (2020): 878-885. doi: https://doi.org/10.1177/2050640620944720
Ammer-Herrmenau C, Pfisterer N, Weingarten MF, Neesse A. The microbiome in pancreatic diseases: Recent advances and future perspectives. United European Gastroenterol J. 2020 Oct;8(8):878-885. doi: 10.1177/2050640620944720. Epub 2020 Jul 23. PMID: 32703080; PMCID: PMC7707879.
Copy Download .nbib Format: NLM
Systematic review and meta-analysis of the performance of nurses in small bowel capsule endoscopy reading.

United European gastroenterology journal

Yung DE, Fernandez-Urien I, Douglas S, Plevris JN, Sidhu R, McAlindon ME, Panter S, Koulaouzidis A.
PMID: 29238584
United European Gastroenterol J. 2017 Dec;5(8):1061-1072. doi: 10.1177/2050640616687232. Epub 2017 Jan 11.

INTRODUCTION: Increasing demands on healthcare systems mean that nurses are taking on more roles as physician extenders. Capsule endoscopy (CE) is a laborious procedure where specialist nurses could reduce physician workload and rationalise resource utilisation. The aim of this...

Cite
Yung DE, Fernandez-Urien I, Douglas S, et al. Systematic review and meta-analysis of the performance of nurses in small bowel capsule endoscopy reading. United European Gastroenterol J. 2017;5(8):1061-1072doi: 10.1177/2050640616687232.
Yung, D. E., Fernandez-Urien, I., Douglas, S., Plevris, J. N., Sidhu, R., McAlindon, M. E., Panter, S., & Koulaouzidis, A. (2017). Systematic review and meta-analysis of the performance of nurses in small bowel capsule endoscopy reading. United European gastroenterology journal, 5(8), 1061-1072. https://doi.org/10.1177/2050640616687232
Yung, Diana E, et al. "Systematic review and meta-analysis of the performance of nurses in small bowel capsule endoscopy reading." United European gastroenterology journal vol. 5,8 (2017): 1061-1072. doi: https://doi.org/10.1177/2050640616687232
Yung DE, Fernandez-Urien I, Douglas S, Plevris JN, Sidhu R, McAlindon ME, Panter S, Koulaouzidis A. Systematic review and meta-analysis of the performance of nurses in small bowel capsule endoscopy reading. United European Gastroenterol J. 2017 Dec;5(8):1061-1072. doi: 10.1177/2050640616687232. Epub 2017 Jan 11. PMID: 29238584; PMCID: PMC5721976.
Copy Download .nbib Format: NLM
Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology.

United European gastroenterology journal

Noben M, Vanhove W, Arnauts K, Santo Ramalho A, Van Assche G, Vermeire S, Verfaillie C, Ferrante M.
PMID: 29238585
United European Gastroenterol J. 2017 Dec;5(8):1073-1081. doi: 10.1177/2050640617722903. Epub 2017 Jul 21.

Determining the exact pathogenesis of chronic gastrointestinal diseases remains difficult due to the complex in vivo environment. In this review we give an overview of the available epithelial cell culture systems developed to investigate pathophysiology of gastrointestinal diseases. Traditionally...

Cite
Noben M, Vanhove W, Arnauts K, et al. Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology. United European Gastroenterol J. 2017;5(8):1073-1081doi: 10.1177/2050640617722903.
Noben, M., Vanhove, W., Arnauts, K., Santo Ramalho, A., Van Assche, G., Vermeire, S., Verfaillie, C., & Ferrante, M. (2017). Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology. United European gastroenterology journal, 5(8), 1073-1081. https://doi.org/10.1177/2050640617722903
Noben, Manuel, et al. "Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology." United European gastroenterology journal vol. 5,8 (2017): 1073-1081. doi: https://doi.org/10.1177/2050640617722903
Noben M, Vanhove W, Arnauts K, Santo Ramalho A, Van Assche G, Vermeire S, Verfaillie C, Ferrante M. Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology. United European Gastroenterol J. 2017 Dec;5(8):1073-1081. doi: 10.1177/2050640617722903. Epub 2017 Jul 21. PMID: 29238585; PMCID: PMC5721984.
Copy Download .nbib Format: NLM
Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.

United European gastroenterology journal

Sadr-Azodi O, Konings P, Brusselaers N.
PMID: 29238591
United European Gastroenterol J. 2017 Dec;5(8):1123-1128. doi: 10.1177/2050640617702060. Epub 2017 Apr 09.

BACKGROUND: The role of menopausal hormone therapy (MHT) in the development of pancreatic cancer is inconclusive owing to small studies and lack of proper study design.METHODS: This population-based matched cohort study included all Swedish women who used systemic MHT...

Cite
Sadr-Azodi O, Konings P, Brusselaers N. Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European Gastroenterol J. 2017;5(8):1123-1128doi: 10.1177/2050640617702060.
Sadr-Azodi, O., Konings, P., & Brusselaers, N. (2017). Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European gastroenterology journal, 5(8), 1123-1128. https://doi.org/10.1177/2050640617702060
Sadr-Azodi, Omid, et al. "Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study." United European gastroenterology journal vol. 5,8 (2017): 1123-1128. doi: https://doi.org/10.1177/2050640617702060
Sadr-Azodi O, Konings P, Brusselaers N. Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European Gastroenterol J. 2017 Dec;5(8):1123-1128. doi: 10.1177/2050640617702060. Epub 2017 Apr 09. PMID: 29238591; PMCID: PMC5721980.
Copy Download .nbib Format: NLM
Severity assessment of acute pancreatitis using four prognostic factors - a nationwide multicenter study of 3682 cases in Japan.

United European gastroenterology journal

Hamada S, Masamune A, Kikuta K, Shimosegawa T.
PMID: 29238593
United European Gastroenterol J. 2017 Dec;5(8):1136-1137. doi: 10.1177/2050640617725961. Epub 2017 Aug 03.

No abstract available.

Cite
Hamada S, Masamune A, Kikuta K, et al. Severity assessment of acute pancreatitis using four prognostic factors - a nationwide multicenter study of 3682 cases in Japan. United European Gastroenterol J. 2017;5(8):1136-1137doi: 10.1177/2050640617725961.
Hamada, S., Masamune, A., Kikuta, K., & Shimosegawa, T. (2017). Severity assessment of acute pancreatitis using four prognostic factors - a nationwide multicenter study of 3682 cases in Japan. United European gastroenterology journal, 5(8), 1136-1137. https://doi.org/10.1177/2050640617725961
Hamada, Shin, et al. "Severity assessment of acute pancreatitis using four prognostic factors - a nationwide multicenter study of 3682 cases in Japan." United European gastroenterology journal vol. 5,8 (2017): 1136-1137. doi: https://doi.org/10.1177/2050640617725961
Hamada S, Masamune A, Kikuta K, Shimosegawa T. Severity assessment of acute pancreatitis using four prognostic factors - a nationwide multicenter study of 3682 cases in Japan. United European Gastroenterol J. 2017 Dec;5(8):1136-1137. doi: 10.1177/2050640617725961. Epub 2017 Aug 03. PMID: 29238593; PMCID: PMC5721985.
Copy Download .nbib Format: NLM
The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms.

United European gastroenterology journal

Sakin YS, Vardar R, Sezgin B, Cetin ZE, Alev Y, Yildirim E, Kirazli T, Bor S.
PMID: 28815026
United European Gastroenterol J. 2017 Aug;5(5):632-640. doi: 10.1177/2050640616675040. Epub 2016 Oct 12.

BACKGROUND: The diagnosis of laryngopharyngeal reflux is currently based on a combination of the patient history of multichannel intraluminal impedance and ambulatory pH (MII-pH); however, none of these findings alone is specific for the diagnosis of laryngopharyngeal reflux. We...

Cite
Sakin YS, Vardar R, Sezgin B, et al. The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms. United European Gastroenterol J. 2016;5(5):632-640doi: 10.1177/2050640616675040.
Sakin, Y. S., Vardar, R., Sezgin, B., Cetin, Z. E., Alev, Y., Yildirim, E., Kirazli, T., & Bor, S. (2017). The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms. United European gastroenterology journal, 5(5), 632-640. https://doi.org/10.1177/2050640616675040
Sakin, Yusuf S, et al. "The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms." United European gastroenterology journal vol. 5,5 (2017): 632-640. doi: https://doi.org/10.1177/2050640616675040
Sakin YS, Vardar R, Sezgin B, Cetin ZE, Alev Y, Yildirim E, Kirazli T, Bor S. The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms. United European Gastroenterol J. 2017 Aug;5(5):632-640. doi: 10.1177/2050640616675040. Epub 2016 Oct 12. PMID: 28815026; PMCID: PMC5548345.
Copy Download .nbib Format: NLM
Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

United European gastroenterology journal

Meijer B, Simsek M, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CM, Mulder CJ, de Boer NK.
PMID: 28815029
United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16.

BACKGROUND: Nodular regenerative hyperplasia is an uncommon liver condition associated with several autoimmune disorders and drugs. The clinical symptoms of nodular regenerative hyperplasia vary from asymptomatic to severe complications of portal hypertension (nodular regenerative hyperplasia-syndrome).OBJECTIVE: The purpose of this...

Cite
Meijer B, Simsek M, Blokzijl H, et al. Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European Gastroenterol J. 2016;5(5):658-667doi: 10.1177/2050640616680550.
Meijer, B., Simsek, M., Blokzijl, H., de Man, R. A., Coenraad, M. J., Dijkstra, G., van Nieuwkerk, C. M., Mulder, C. J., & de Boer, N. K. (2017). Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European gastroenterology journal, 5(5), 658-667. https://doi.org/10.1177/2050640616680550
Meijer, Berrie, et al. "Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units." United European gastroenterology journal vol. 5,5 (2017): 658-667. doi: https://doi.org/10.1177/2050640616680550
Meijer B, Simsek M, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CM, Mulder CJ, de Boer NK. Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units. United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16. PMID: 28815029; PMCID: PMC5548351.
Copy Download .nbib Format: NLM
Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments.

United European gastroenterology journal

Walter T, Zhenzhen Wang C, Guillaud O, Cotte E, Pasquer A, Vinet O, Poncet G, Ponchon T, Saurin JC.
PMID: 28815038
United European Gastroenterol J. 2017 Aug;5(5):735-741. doi: 10.1177/2050640616678150. Epub 2016 Oct 28.

BACKGROUND: Desmoid tumours represent a major complication of familial adenomatous polyposis. Our aims were to study the factors associated with the development of desmoid tumours in familial adenomatous polyposis patients, and to describe presentation and management of desmoid tumours.METHODS...

Cite
Walter T, Zhenzhen Wang C, Guillaud O, et al. Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments. United European Gastroenterol J. 2016;5(5):735-741doi: 10.1177/2050640616678150.
Walter, T., Zhenzhen Wang, C., Guillaud, O., Cotte, E., Pasquer, A., Vinet, O., Poncet, G., Ponchon, T., & Saurin, J. C. (2017). Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments. United European gastroenterology journal, 5(5), 735-741. https://doi.org/10.1177/2050640616678150
Walter, T, et al. "Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments." United European gastroenterology journal vol. 5,5 (2017): 735-741. doi: https://doi.org/10.1177/2050640616678150
Walter T, Zhenzhen Wang C, Guillaud O, Cotte E, Pasquer A, Vinet O, Poncet G, Ponchon T, Saurin JC. Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments. United European Gastroenterol J. 2017 Aug;5(5):735-741. doi: 10.1177/2050640616678150. Epub 2016 Oct 28. PMID: 28815038; PMCID: PMC5548349.
Copy Download .nbib Format: NLM
Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood.

United European gastroenterology journal

Kivelä L, Popp A, Arvola T, Huhtala H, Kaukinen K, Kurppa K.
PMID: 30228890
United European Gastroenterol J. 2018 Aug;6(7):1022-1031. doi: 10.1177/2050640618778386. Epub 2018 May 17.

BACKGROUND: The diagnostic yield of coeliac disease could be improved by screening in at-risk groups, but long-term benefits of this approach are obscure.OBJECTIVE: To investigate health, quality of life and dietary adherence in adult coeliac patients diagnosed in childhood...

Cite
Kivelä L, Popp A, Arvola T, et al. Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United European Gastroenterol J. 2018;6(7):1022-1031doi: 10.1177/2050640618778386.
Kivelä, L., Popp, A., Arvola, T., Huhtala, H., Kaukinen, K., & Kurppa, K. (2018). Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United European gastroenterology journal, 6(7), 1022-1031. https://doi.org/10.1177/2050640618778386
Kivelä, Laura, et al. "Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood." United European gastroenterology journal vol. 6,7 (2018): 1022-1031. doi: https://doi.org/10.1177/2050640618778386
Kivelä L, Popp A, Arvola T, Huhtala H, Kaukinen K, Kurppa K. Long-term health and treatment outcomes in adult coeliac disease patients diagnosed by screening in childhood. United European Gastroenterol J. 2018 Aug;6(7):1022-1031. doi: 10.1177/2050640618778386. Epub 2018 May 17. PMID: 30228890; PMCID: PMC6137595.
Copy Download .nbib Format: NLM
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients.

United European gastroenterology journal

Aghdaei HA, Kadijani AA, Sorrentino D, Mirzaei A, Shahrokh S, Balaii H, Geraci M, Zali MR.
PMID: 30228896
United European Gastroenterol J. 2018 Aug;6(7):1074-1081. doi: 10.1177/2050640618774637. Epub 2018 May 02.

BACKGROUND: Predicting the response of inflammatory bowel disease (IBD) patients to infliximab (IFX) is an unmet clinical need. The expression and density of transmembrane tumor necrosis factor-α in circulating leukocytes maybe directly related to response by promoting apoptosis.AIM: We...

Cite
Aghdaei HA, Kadijani AA, Sorrentino D, et al. An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients. United European Gastroenterol J. 2018;6(7):1074-1081doi: 10.1177/2050640618774637.
Aghdaei, H. A., Kadijani, A. A., Sorrentino, D., Mirzaei, A., Shahrokh, S., Balaii, H., Geraci, M., & Zali, M. R. (2018). An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients. United European gastroenterology journal, 6(7), 1074-1081. https://doi.org/10.1177/2050640618774637
Aghdaei, Hamid Asadzadeh, et al. "An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients." United European gastroenterology journal vol. 6,7 (2018): 1074-1081. doi: https://doi.org/10.1177/2050640618774637
Aghdaei HA, Kadijani AA, Sorrentino D, Mirzaei A, Shahrokh S, Balaii H, Geraci M, Zali MR. An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients. United European Gastroenterol J. 2018 Aug;6(7):1074-1081. doi: 10.1177/2050640618774637. Epub 2018 May 02. PMID: 30228896; PMCID: PMC6137581.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1343 entries